Biofarma Holding A/S: Financial statements 2024
CVR: 42243795
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Biofarma Holding A/S (CVR 42243795) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK 9,891,485 compared with DKK 4,938,666 the year before. Equity in the 2024 report amounted to DKK 93,661,357. The solvency ratio was 99.5%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK 9,891,485
- Equity
- DKK 93,661,357
- Total Assets
- DKK 94,097,829
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | 9.9 mio. | 93.7 mio. | 1 |
| 2023 | - | 0 | 4.9 mio. | 83.8 mio. | 0 |
| 2022 | 0 | 0 | -515 t. | 77.6 mio. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Biofarma Holding A/S has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 4,938,666.
About Biofarma Holding A/S
Biofarma Holding A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Søren Wang Petersen. The board consists of Tyge Jesper Rothe (chair), Niels Christian Assens and Søren Wang Petersen. The company is owned by CAND.PHARM. POVL M. ASSENS FOND. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 10,281,000 compared with DKK 9,891,485 the year before. Equity in the 2025 report amounted to DKK 103,544,000.